GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Research & Development

CurveBeam AI (ASX:CVB) Research & Development : A$0.48 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CurveBeam AI's Research & Development for the six months ended in Dec. 2023 was A$0.48 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.48 Mil.

CurveBeam AI Research & Development Historical Data

The historical data trend for CurveBeam AI's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Research & Development Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Research & Development
- - 0.59

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Research & Development - - - - 0.48

CurveBeam AI Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI  (ASX:CVB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CurveBeam AI Research & Development Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Research & Development
Comparable Companies
ASX:COV ASX:CSX ASX:ADR ASX:CDX ASX:OSL ASX:CMP ASX:AT1 ASX:RSH ASX:HMD ASX:EYE ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Website
https://www.curvebeamai.com
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines